235
Views
4
CrossRef citations to date
0
Altmetric
Letter

CD20 expression in angioimmunoblastic T cell lymphoma

, , , , , , , , , & show all
Pages 345-347 | Received 21 Jan 2011, Accepted 27 Jun 2011, Published online: 15 Nov 2011

References

  • Dogan A, Gaulard P, Jaffe ES, . Angioimmunoblastic T-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, . editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2008. p 309–311.
  • Van Dongen JJ, Langerak AW, Brüggemann M, . Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17(12): 2257–2317.
  • Willenbrock K, Bräuninger A, Hansmann ML. Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases. Br. J. Haematol 2007; 138: 733–739.
  • de Leval L, Rickman DS, Thielen C, . The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007; 109: 4952–4963.
  • Piccaluga PP, Agostinelli C, Califano A, . Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 2007; 67: 10703–10710.
  • Rahemtullah A, Longtine JA, Harris NL, . CD20+ T-cell lymphoma. Clinicopathologic analysis of 9 cases and a review of the literature. Am. J. Surg. Pathol 2008; 32: 1593–1607.
  • Yokose N, Ogata K, Sugisaki Y, . CD20-positive T cell leukemia/lymphoma: case report and review of the literature. Ann Hematol 2001; 80: 372–375.
  • Quintanilla-Martinez L, Preffer F, Rubin D, . CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset. Am. J. Clin. Pathol 1994; 102: 483–489.
  • Sun T, Akalin A, Rodacker M, . CD20 positive T cell lymphoma: is it a real entity? J. Clin. Pathol 2004; 57: 442–444.
  • Joly B, Plonquet A, Grare M, . Rituximab in combination with CHOP regimen in angioimmunoblastic T-cell lymphoma: Results of the phase II RAIL trial-A prospective study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA). J. Clin. Oncol (ASCO Annual Meeting) 2010; 28: Abstract 8049.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.